Human Genome Sciences received and declined it's first buyout offer from GSK in April 2012
HGSI was purchased at a higher premium later that year by Glaxo.
The Street downgraded INHX in Dec 2011.
Inhibitex was purchased by Bristol-Myers in Jan 2012.
Don't let Cramer and his cronies scare you out of your shares.
The most predictive bullish sign of all is upon us....
Cramer and Nomad are in alignment wrt EXEL. Scary, but you are seeing it right here, right now...
Nomad and Cramer - together again for the first time. Anything can happen...
If I remember right, the Medarex message board was full of pessimism and fear about whether or not the results would be positive and the fact that the stock price had not risen with stockholders expectations of a price increase. Then after a period of weeks/months, they anounced they were selling the company. I'm not saying Exel will be sold but there is starting to be a bit more negativity on this board because the price has gone nowhere. We'll see in the next 6 to 18 months. I'm willing to wait.